Changes in the free-radical state and the level of free iron during the development of drug resistance in tumor cells

被引:0
|
作者
Saprin A.N. [1 ]
Kalinina E.V. [1 ,2 ]
Serezhenkov V.A. [3 ]
Kotova Ya.N. [1 ]
Solomka V.S. [1 ]
Shcherbak N.P. [4 ]
机构
[1] Center of Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences, Moscow, 119991
[2] Research Institute of Cytochemistry and Molecular Pharmacology, Moscow, 115404
[3] Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, 117977
[4] Institute of Carcinogenesis, Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, 115478
关键词
Drug resistance; Free-radical processes; Intracellular pool of free iron;
D O I
10.1134/S0006350906030158
中图分类号
学科分类号
摘要
The free-radical state of K562 human erythroleukemia cells changes during the development of resistance to doxorubicin, an antitumor antibiotic with prooxidant action widely used in oncology. It was found that the level of superoxide anion in the resistant cells decreased. The addition of doxorubicin to the culture medium induced a much smaller increase in O 2 ̇ generation in the resistant cells than in the sensitive cells. Again, the semiquinone-type EPR signal with a g-factor of 2.006 considerably decreased in the resistant cells grown without doxorubicin as compared with the sensitive cells under the same conditions. The EPR study has shown that the level of paramagnetic nitrosyl complexes of nonheme iron in the resistant cells decreased, which indicates that the content of free nonheme iron declined in development of drug resistance. In addition, we have found with the use of RT-PCR that the level of mRNA of the transferrin receptor decreased in the resistant cells. The data suggest that the suppression of free-radical processes during the development of resistance of K562 cells to doxorubicin is a coordinated redox-dependent adaptive response. © Nauka/Interperiodica 2006.
引用
收藏
页码:435 / 439
页数:4
相关论文
共 19 条
  • [1] Changes in the free-radical state and the content of free iron during the formation of drug resistance of tumor cells
    Saprin, AN
    Kalinina, EV
    Serezhenkov, VA
    Kotova, YN
    Solomka, VS
    Scherbak, NP
    BIOFIZIKA, 2006, 51 (03): : 485 - 490
  • [2] ROLE OF OXYGEN FREE-RADICAL FORMATION IN THE MECHANISM OF MENOGARIL RESISTANCE IN MULTIDRUG RESISTANT TUMOR-CELLS
    SINHA, BK
    ATWELL, J
    POLITI, PM
    CHEMICO-BIOLOGICAL INTERACTIONS, 1990, 76 (01) : 89 - 99
  • [3] Investigation of the level of free-radical processes in substrates and biological samples using induced chemiluminescence
    Piskarev I.M.
    Trofimova S.V.
    Burkhina O.E.
    Ivanova I.P.
    Biophysics, 2015, 60 (3) : 400 - 408
  • [4] Histamine-Dependent Changes in Free Radical Processes during Coronary Heart Disease
    A. A. Stremoukhov
    Bulletin of Experimental Biology and Medicine, 2001, 132 : 1157 - 1159
  • [5] Histamine-dependent changes in free radical processes during coronary heart disease
    Stremoukhov, AA
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 132 (06) : 1157 - 1159
  • [6] Influence of the succinate-containing substances on activity of the organism free-radical processes, a structure of the liver and on tumor of rats with the Pliss lymphosarcoma
    Moskovtseva, O. M.
    Ivanova, N. L.
    Sherbatyuk, T. G.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2010, (03) : 24 - 28
  • [7] MicroRNA Expression Profiles Associated with Development of Drug Resistance in Ehrlich Ascites Tumor Cells
    Husted, Susanne
    Sokilde, Rolf
    Rask, Lene
    Cirera, Susanna
    Busk, Peter Kamp
    Eriksen, Jens
    Litman, Thomas
    MOLECULAR PHARMACEUTICS, 2011, 8 (06) : 2055 - 2062
  • [8] THE DEVELOPMENT OF DRUG-RESISTANCE BY TUMOR-CELLS IN-VITRO IS ACCOMPANIED BY THE DEVELOPMENT OF SENSITIVITY TO SELENITE
    CAFFREY, PB
    FRENKEL, GD
    CANCER LETTERS, 1994, 81 (01) : 59 - 65
  • [9] Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance
    Nilendu, Pritish
    Sarode, Sachin C.
    Jahagirdar, Devashree
    Tandon, Ishita
    Patil, Shankargouda
    Sarode, Gargi S.
    Pal, Jayanta K.
    Sharma, Nilesh Kumar
    CELLULAR ONCOLOGY, 2018, 41 (04) : 353 - 367
  • [10] Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance
    Pritish Nilendu
    Sachin C. Sarode
    Devashree Jahagirdar
    Ishita Tandon
    Shankargouda Patil
    Gargi S. Sarode
    Jayanta K. Pal
    Nilesh Kumar Sharma
    Cellular Oncology, 2018, 41 : 353 - 367